Skip to content

A clinical study on the accuracy, safety and efficacy of hip intra-articular injection guided by portable ultrasound

A clinical study on the accuracy, safety and efficacy of hip intra-articular injection guided by portable ultrasound

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300074174
Enrollment
Unknown
Registered
2023-08-01
Start date
2023-08-01
Completion date
Unknown
Last updated
2023-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip Cartilage Injuries

Interventions

Group of using anatomical landmarks intra-articular injections:Performing intra-articular injections by using anatomical landmarks
Group of conventional musculoskeletal ultrasound-guided intra-articular injections:Performing intra-articular injections by using conventional musculoskeletal ultrasound-guided
Group of portable ultrasound-guided intra-articular injections:Performing intra-articular injections by using portable ultrasound-guided

Sponsors

Center for Joint Surgery, the First Affiliated Hospital, Army Medical University, Chongqing, China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Patients with fibrocartilage injury, i.e., labral injury. This includes patients with a clinical diagnosis of hip impingement (FAI) and congenital developmental dysplasia of the hip (DDH), who have the femoral head in place and have not yet secondary severe degenerative changes (tornis grade 0-2), who have secondary glenoid labral tears confirmed by MRI resulting in hip pain, and who do not have a long history of the disease, and who are suitable for conservative treatment or who refuse surgical treatment and only receive injection therapy; (2) Hyaline cartilage injury, i.e., patients clinically diagnosed with osteoarthritis (OA) of the hip, with a tornis grade of 0-2, suitable for conservative treatment or refusing surgical treatment and receiving only injection therapy; (3) Patients receiving and suitable for conservative treatment; (4) Follow-up is possible; (5) Normal heart function, liver and kidney function, and blood picture; (6) Patients signed the informed consent. Included patients must fulfill any one of items (1) and (2), and must also fulfill items (3) to (6).

Exclusion criteria

Exclusion criteria: (1) FAI secondary to severe hip OA (tornis grade 3) is not suitable for conservative treatment; (2) DDH patients with dislocation of the femoral head, formation of a "false socket", severe deformity of the acetabulum and filling of the acetabulum with adipose and fibrous tissue are not suitable for conservative treatment; (3) Hip OA patients, tornis grade 3 is not suitable for conservative treatment; (4) Systemic arthritis such as rheumatoid and ankylosing spondylitis; (5) Accompanied by serious active infection or serious diseases of heart, liver, kidney and hematopoietic system; (6) Patients do not accept hip puncture injection therapy; (7) Poor compliance. Patients fulfilling any of the items (1) to (7) meet the exclusion criteria.

Design outcomes

Primary

MeasureTime frame
Accuracy and success of intra-articular hip injections;Pain level of intra-articular injection operations;Time spent on intra-articular injection;Evaluation of Hip Function and Pain;

Secondary

MeasureTime frame
Body Mass Index;Number of intra-articular injections from start of injection to ultrasound confirmation of successful injection;Distance from needle tip to skin edge;

Countries

China

Contacts

Public ContactGuangxing Chen

Center for Joint Surgery, the First Affiliated Hospital, Army Medical University, Chongqing, China

cgx7676@hotmail.com+86 186 2310 8787

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026